enVVeno Medical regains compliance with Nasdaq minimum bid price rule

enVVeno Medical (NVNO) has received formal notice from the Listings Qualifications staff of The Nasdaq Stock Marketthat the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. Nasdaq confirmed that for the last 10 consecutive business days, from January 20, 2026 through February 2, 2026, the closing bid price of the Company’s common stock was at or above $1.00, and as a result, the matter is now closed.